Home›Stock Screener›Abate AS Industries

Abate AS Industries Share Price Today | Stock Price & Abate AS Industries Share Screener

ABATEAS Healthcare Services
Live Share Price BSE
₹7.16
▲ 0.11 (1.56%)
2026-11-20 00:00:00

As of November 20, 2026, the live Abate AS Industries share price (BSE: ABATEAS) is ₹7.16, up 1.56% from the previous close, with shares trading between ₹6.75 and ₹7.59 in today's trading session, and a 52-week range of ₹6.57–₹18.92. Track Abate AS Industries market cap to gauge the company's total market size. Use the Abate AS Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Abate AS Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹35 and net income of ₹3, with EBITDA of ₹4, an operating margin of 9.0% and a profit margin of 8.6%.

Abate AS Industries Market Cap ₹115.03 Cr.
ABATEAS P/E Ratio (TTM) 8.80
Abate AS Industries P/B Ratio 0.62
EPS (TTM) ₹0.54
Dividend Yield -
Debt to Equity 0.06
ABATEAS 52 Week High ₹18.92
Abate AS Industries 52 Week Low ₹6.57
Operating Margin 9.00%
Profit Margin 8.57%
ABATEAS Revenue (TTM) ₹35.00
EBITDA ₹4.00
Net Income ₹3.00
Total Assets ₹223.00
Total Equity ₹199.00

Abate AS Industries Share Price Chart

Track the current stock price of Abate AS Industries with an interactive chart. Analyse ABATEAS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Abate AS Industries stock quote in one place.

The quote of ₹7.16 sits between the 52-week low of ₹6.57 and the 52-week high of ₹18.92, and the latest session moved 1.56% from the previous close.

Abate AS Industries Company Profile - Fundamental Screener

Screen Abate AS Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABATEAS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE454E01013.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE454E01013

Abate AS Industries Balance Sheet Screener

Screen ABATEAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹223, up from ₹206 in 2025.

Latest statistics put total assets at ₹223 and shareholder funds at ₹199, with a leverage ratio of 0.06.

Item 2026 2025

Assets

Total Assets 223 206
Current Assets 0 0
Fixed Assets 150 149

Liabilities

Total Liabilities 0 0
Current Liabilities 3 4
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 199 186
Share Capital 158 79
Reserves & Surplus 16 85

Abate AS Industries Income Statement Screener - Profit & Revenue Analysis

Screen Abate AS Industries income statement and profit fundamentals. Analyze ABATEAS quarterly results. Abate AS Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹35 and net profit was ₹3, equal to earnings per unit of ₹0.13, at an operating margin of 9%.

In that period expenses were ₹31, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹23 and net profit of ₹2.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Jun 2024-Sept 2024-Dec

Revenue and Expenses

Revenue 35 23 26 15 42 43 43 0 0 0
Expenses 31 20 22 13 39 38 39 0 0 0

Operating Costs and Margins

EBITDA 4 4 4 2 3 5 4 0 0 0
Operating Profit % 9.00% 15.00% 13.00% 6.00% 6.00% 9.00% 9.00% 0.00% 0.00% 0.00%
Depreciation 1 1 1 1 1 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 3 3 3 1 2 4 3 0 0 0
Tax 0 1 0 0 0 0 0 0 0 0
Net Profit 3 2 3 1 2 4 3 0 0 0
EPS 0.13 0.08 0.10 0.24 0.10 0.19 0.13 -0.07 -0.05 -0.05

Abate AS Industries Cash Flow Screener - Liquidity Fundamentals

Screen ABATEAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹6, and net cash flow was an inflow of ₹2.

Over the same period, investing activities used ₹2 and financing activities used ₹2.

Item 2026-March 2025-March

Cash from Operations and Investing

Operating Activities 6 -1
Investing Activities -2 -162

Financing and Net Cash

Financing Activities -2 165
Net Cash Flow 2 2

Abate AS Industries Shareholding Pattern Screener

See Abate AS Industries shareholding pattern with promoter, FII, and DII holdings. Check Abate AS Industries promoter holding and ownership changes for ABATEAS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 32.42%, foreign institutions 0.00%, domestic institutions 0.00% and the public 14.69%, spread across 3,568 shareholders.

The shareholder count was 3,568 in 2026-Sept, compared with 3,314 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Aug 2025-Jun 2025-May

Promoter Holding

Promoter Holding 32.42% 32.42% 32.42% 27.56% 27.56% 27.56% 27.56% 27.56%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 14.69% 14.55% 13.87% 3.83% 47.50% 47.45% 47.42% 47.31%
Other Holding 52.89% 53.04% 53.71% 68.60% 24.94% 24.99% 25.02% 25.12%
Shareholder Count 3,568 3,314 3,030 2,580 2,435 2,272 1,050 1,057

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Abate AS Industries. Abate AS Industries dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Abate AS Industries.

Abate AS Industries Stock Index Membership - Nifty & Sensex

See which indices include Abate AS Industries stock. Check ABATEAS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Abate AS Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Abate AS Industries Market Events Screener - Corporate Actions

Get Abate AS Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Abate AS Industries stock events that may affect ABATEAS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2026, with a record date of November 12, 2026.

It is followed by Annual General Meeting dated September 16, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-12 2026-11-12 Quarterly Result Announcement NA 12.24%
2026-09-16 2026-09-16 Annual General Meeting NA -10.79%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -1.35%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 1.00%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 16.76%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 0.06%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -5.79%
2025-07-31 2025-07-31 Bonus 1:1 1.79%
2025-07-14 2025-07-14 Annual General Meeting NA 84.58%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 0.00%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 4.98%
2025-02-05 2025-02-05 Extraordinary General Meeting NA 0.00%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -4.98%
2024-09-11 2024-09-11 Annual General Meeting NA -10.98%
2021-10-22 2021-10-22 Change Of Name NA -

Abate AS Industries Competitors Screener - Peer Stocks Comparison

Screen ABATEAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,114 52.40 25,420 15.58% 2,003 64.36
Max Healthcare Institute 98,295 66.60 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 90,925 98.70 10,521 25.80% 917 58.01
Aster DM Quality Care 65,375 111.60 4,769 11.25% 427 61.53
Fortis Healthcare 60,638 54.40 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 38,733 44.30 7,996 43.43% 811 60.17
Global Health 38,545 63.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,582 56.90 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 32,061 155.60 3,931 28.16% 242 65.46
Syngene International 17,810 96.50 3,809 2.56% 317 66.04

Abate AS Industries Company Announcements - News & Reports Screener

Screen ABATEAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 20, 2026.

The next most recent announcements are dated November 19, 2026 and November 19, 2026.

Date Update Actions
2026-11-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-19 Results For The Quarter And Half Year Ended 30Th September 2026 -
2026-11-19 Board Meeting Outcome for Submission Of Outcome Of Board Meeting. -
2026-11-05 Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September 2026. -
2026-10-14 Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Closure of Trading Window -
2026-09-17 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-16 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-24 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-22 Submission Of Notice Of Annual General Meeting. -
2026-08-22 Announcement Under Reg 36(1)(B) Of SEBI (LODR) Regulations2015. -
2026-08-22 Submission Of Intimation Of Record Date. -
2026-08-22 Submission Of Intimation Of Book Closure And Cut-Off Date. -
2026-08-22 Reg. 34 (1) Annual Report. -
2026-08-21 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-18 Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2026-08-13 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-13 Announcement under Regulation 30 (LODR)-Change in Directorate -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹7.16, within a 52-week range of ₹6.57 to ₹18.92. The P/E ratio is 8.80 and the P/B ratio is 0.62, with earnings per unit of ₹0.54. Market capitalisation stands at ₹115.03 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 22, 2026. This page covers 2 balance sheet periods, 10 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.